The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites

Microbes and Infection

Volumn 5, Issue 6, 2003, Pages 499-506

  Schmieg, John ^a   Gonzalez Aseguinolaza, Gloria ^b   Tsuji, Moriya ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Malaria; Natural killer T cells; Pre erythrocytic stages; Protective immunity

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFECT; ERYTHROCYTE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; LIVER; LYMPHOCYTE FUNCTION; MALARIA; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PLASMODIUM; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 0037691923     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00072-8     Document Type: Review

References (34)

1. Nussenzweig V., Nussenzweig R.S. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:1989;283-334.
2. Chen D.H., Tigelaar R.E., Weinbaum F.I. Immunity to sporozoite-induced malaria infection in mice. I. The effect of immunization of T and B cell-deficient mice. J. Immunol. 118:1977;1322-1327.
3. Schofield L., Villaquiran J., Ferreira A., Schellekens H., Nussenzweig R., Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature. 330:1987;664-666.
4. Weiss W.R., Sedegah M., Beaudoin R.L., Miller L.H., Good M.F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA. 85:1988;573-576.
5. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 341:1989;323-326.
6. Rodrigues M.M., Cordey A.S., Arreaza G., Corradin G., Romero P., Maryanski J.L., Nussenzweig R.S., Zavala F. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3:1991;579-585.
7. Khusmith S., Sedegah M., Hoffman S.L. Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizingsporozoite surface protein 2. Inf. Immun. 62:1994;2979-2983.
8. Doolan D.L., Hedstrom R.C., Rogers W.O., Charoenvit Y., Rogers M., de la Vega P., Hoffman S.L. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J. Biol. Chem. 271:1996;17861-17868.
9. Seguin M.C., Klotz F.W., Schneider I., Weir J.P., Goodbary M., Slayter M., Raney J.J., Aniagolu J.U., Green S.J. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J. Exp. M. 180:1994;353-358.
10. Aidoo M., Lalvani A., Allsopp C.E., Plebanski M., Meisner S.J., Krausa P., Browning M., Morris-Jones S., Gotch F., Fidock D.A., et al. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet. 345:1995;1003-1007.
11. Hill A.V., Elvin J., Willis A.C., Aidoo M., Allsopp C.E., Gotch F.M., Gao X.M., Takiguchi M., Greenwood B.M., Townsend A.R., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360:1992;434-439.
12. Rodrigues M., Nussenzweig R.S., Zavala F. The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology. 80:1993;1-5.
13. Tsuji M., Romero P., Nussenzweig R.S., Zavala F. CD4+ cytolytic T cell clone confers protection against murine malaria. J. Exp. M. 172:1990;1353-1357.
14. Takita-Sonoda Y., Tsuji M., Kamboj K., Nussenzweig R.S., Clavijo P., Zavala F. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp. Parasitol. 84:1996;223-230.
15. Molano A., Park S.H., Chiu Y.H., Nosseir S., Bendelac A., Tsuji M. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J. Immunol. 164:2000;5005-5009.
16. Carvalho L.H., Sano G., Hafalla J.C., Morrot A., Curotto de Lafaille M.A., Zavala F. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nature M. 8:2002;166-170.
17. Good M.F., Pombo D., Quakyi I.A., Riley E.M., Houghten R.A., Menon A., Alling D.W., Berzofsky J.A., Miller L.H. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc. Natl. Acad. Sci. USA. 85:1998;1199-1203.
18. Tsuji M., Mombaerts P., Lefrancois L., Nussenzweig R.S., Zavala F., Tonegawa S. Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc. Natl. Acad. Sci. USA. 91:1994;345-349.
19. McKenna K.C., Tsuji M., Sarzotti M., Sacci J.B. Jr, Witney A.A., Azad A.F. Gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites. Infect. Immun. 68:2000;2224-2230.
20. Doolan D.L., Hoffman S.L. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J. Immunol. 163:1999;884-892.
21. Slifka M.K., Pagarigan R.R., Whitton J.L. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J. Immunol. 164:2000;2009-2015.
22. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:1997;535-562.
23. Kobayashi E., Motoki K., Uchida T., Fukushima H., Koezuka Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol. Res. 7:1995;529-535.
24. Schofield L., McConville M.J., Hansen D., Campbell A.S., Fraser-Reid B., Grusby M.J., Tachado S.D. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science. 283:1999;225-229.
25. Romero J.F., Eberl G., MacDonald H.R., Corradin G. CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice. Parasite Immunol. 23:2001;267-269.
26. Krzych U., Schwenk R., Guebre-Xabier M., Sun P., Palmer D., White K., Chalom I. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol. Rev. 174:2000;123-134.
27. Pied S., Roland J., Louise A., Voegtle D., Soulard V., Mazier D., Cazenave P.A. Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J. Immunol. 164:2000;1463-1469.
28. Weerasinghe A., Sekikawa H., Watanabe H., Mannoor K., Morshed S.R., Halder R.C., Kawamura T., Kosaka T., Miyaji C., Kawamura H., Seki S., Abo T. Association of intermediate T cell receptor cells, mainly their NK1.1(-) subset, with protection from malaria. Cell. Immunol. 207:2001;28-35.
29. Mannoor M.K., Halder R.C., Morshed S.R., Ariyasinghe A., Bakir H.Y., Kawamura H., Watanabe H., Sekikawa H., Abo T. Essential role of extrathymic T cells in protection against malaria. J. Immunol. 169:2002;301-306.
30. Gonzalez-Aseguinolaza G., de Oliveira C., Tomaska M., Hong S., Bruna-Romero O., Nakayama T., Taniguchi M., Bendelac A., Van Kaer L., Koezuka Y., Tsuji M. Alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA. 97:2000;8461-8466.
31. Nishimura T., Nakui M., Sato M., Iwakabe K., Kitamura H., Sekimoto M., Ohta A., Koda T., Nishimura S. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother. Pharmacol. 46:2000;S52-S61.
32. Singh N., Hong S., Scherer D.C., Serizawa I., Burdin N., Kronenberg M., Koezuka Y., Van Kaer L. Cutting edge: activation of NK T cells byCD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163:1999;2373-2377.
33. Nakagawa R., Nagafune I., Tazunoki Y., Ehara H., Tomura H., Iijima R., Motoki K., Kamishohara M., Seki S. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J. Immunol. 166:2001;6578-6584.
34. Gonzalez-Aseguinolaza G., Van Kaer L., Bergmann C.C., Wilson J.M., Schmieg J., Kronenberg M., Nakayama T., Taniguchi M., Koezuka Y., Tsuji M. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. M. 195:2002;617-624.